These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15386808)

  • 21. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes.
    Cheng X; Cheng XS; Kuo KH; Pang CC
    Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
    Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
    Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Chou TF; Cho YL; Chi TC; Su MJ; Tseng YZ
    Eur J Clin Invest; 2006 Jan; 36(1):1-7. PubMed ID: 16403003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
    Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J
    Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes.
    Somogyi A; Ruzicska E; Blázovics A; Vér A; Rosta K; Tóth M
    Med Sci Monit; 2005 Jul; 11(7):BR206-11. PubMed ID: 15990681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic administration of genistein improves aortic reactivity of streptozotocin-diabetic rats: mode of action.
    Baluchnejadmojarad T; Roghani M
    Vascul Pharmacol; 2008 Jul; 49(1):1-5. PubMed ID: 18468493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification.
    Roy M; Sen S; Chakraborti AS
    Life Sci; 2008 May; 82(21-22):1102-10. PubMed ID: 18440560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats.
    Joharchi K; Jorjani M
    Eur J Pharmacol; 2007 Sep; 570(1-3):66-71. PubMed ID: 17599829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.
    Wendt MC; Daiber A; Kleschyov AL; Mülsch A; Sydow K; Schulz E; Chen K; Keaney JF; Lassègue B; Walter U; Griendling KK; Münzel T
    Free Radic Biol Med; 2005 Aug; 39(3):381-91. PubMed ID: 15993337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the altered nitric oxide metabolism in experimental diabetes].
    Tábi T; Soltész Z; Magyar K; Szöko E
    Acta Pharm Hung; 2006; 76(1):19-23. PubMed ID: 17094672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebroventricular injection of neuronal and inducible nitric oxide synthase inhibitors attenuates fever due to LPS in rats.
    Soszynski D; Chelminiak M
    J Physiol Pharmacol; 2007 Sep; 58(3):551-61. PubMed ID: 17928650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats.
    Ebermann L; Spillmann F; Sidiropoulos M; Escher F; Heringer-Walther S; Schultheiss HP; Tschöpe C; Walther T
    Eur J Pharmacol; 2008 Aug; 590(1-3):276-80. PubMed ID: 18571157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.
    Cameron NE; Cotter MA
    Metabolism; 1996 Sep; 45(9):1147-52. PubMed ID: 8781303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes.
    Cheng X; Xia Z; Leo JM; Pang CC
    Eur J Pharmacol; 2005 Sep; 519(1-2):118-26. PubMed ID: 16111676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.